САЩ - английски - NLM (National Library of Medicine)

a-s medication solutions - clostridium tetani toxoid antigen (formaldehyde inactivated) (unii: k3w1n8yp13) (clostridium tetani toxoid antigen (formaldehyde inactivated) - unii:k3w1n8yp13), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (unii: irh51qn26h) (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) - unii:irh51qn26h) - tenivac® is a vaccine indicated for active immunization for the prevention of tetanus and diphtheria in persons 7 years of age and older. a severe allergic reaction (e.g., anaphylaxis) after a previous dose of tenivac or any other tetanus toxoid or diphtheria toxoid-containing vaccine or any other component of this vaccine is a contraindication to administration of tenivac. [see description (11) .] because of uncertainty as to which component of the vaccine may be responsible, none of the components should be administered. alternatively, such individuals may be referred to an allergist for evaluation if further immunizations are to be considered. risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes. in the us general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. there are no adequate and well-controlled studies of tenivac administration in pregnant women in t

САЩ - английски - NLM (National Library of Medicine)

glaxosmithkline biologicals sa - clostridium tetani toxoid antigen (formaldehyde inactivated) (unii: k3w1n8yp13) (clostridium tetani toxoid antigen (formaldehyde inactivated) - unii:k3w1n8yp13), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (unii: irh51qn26h) (corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) - unii:irh51qn26h), bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) (unii: qsn5xo8zsu) (bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) - unii:qsn5xo8zsu), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (unii: 8c367iy4ey) (bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) - unii:8c367iy4ey), bordetella pertussis pertactin antigen (formaldehyde inactivated) (unii: i05o535nv6) (bordetella pertussis pertactin antigen (formaldehyde inactivated) - unii:i05o535nv6) - clostridium tetani toxoid antigen (formaldehyde inactivated) 10 [iu] in 0.5 ml - infanrix is indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks through 6 years (prior to the seventh birthday). severe allergic reaction (e.g., anaphylaxis) after a previous dose of any diphtheria toxoid-, tetanus toxoid-, or pertussis-containing vaccine, or to any component of infanrix is a contraindication [see description (11)] . because of the uncertainty as to which component of the vaccine might be responsible, no further vaccination with any of these components should be given. alternatively, such individuals may be referred to an allergist for evaluation if immunization with any of these components is being considered. encephalopathy (e.g., coma, decreased level of consciousness, prolonged seizures) within 7 days of administration of a previous dose of a pertussis-containing vaccine that is not attributable to another identifiable cause is a contraindication to administration of any pertussis-containing vaccine, including infanrix. progressive neurologic disorder, including infantile spasms, uncontrolled epilepsy, or progressive encephalopathy, is a contraindication to administration of any pertussis-containing vaccine, including infanrix. pertussis vaccine should not be administered to individuals with these conditions until a treatment regimen has been established and the condition has stabilized. safety and effectiveness of infanrix in infants aged younger than 6 weeks and children aged 7 to 16 years have not been established. infanrix is not approved for use in these age groups.

Австралия - английски - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - clostridium haemolyticum; clostridium perfringens type b toxoid; clostridium perfringens type c toxoid; clostridium chauvoei whole cell culture; clostridium novyi tybe b toxiod and inactivated cells; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; thiomersal; aluminium (adjuvant) - misc. vaccines or anti sera - clostridium haemolyticum vaccine-toxoid active 21.2 tcp u/ml; clostridium perfringens type b toxoid vaccine-toxoid active 30.6 tcp u/ml; clostridium perfringens type c toxoid vaccine-toxoid active 15.3 tcp u/ml; clostridium chauvoei whole cell culture vaccine-microbial active 30.0 %ferm/ml; clostridium novyi tybe b toxiod and inactivated cells vaccine-toxiod active 5.95 tcp u/ml; clostridium perfringens type d toxoid vaccine-toxoid active 55.3 tcp u/ml; clostridium septicum - toxoid vaccine-toxoid active 6.4 tcp u/ml; clostridium tetani - toxoid vaccine-toxoid active 3.0 lf u/ml; thiomersal mercury other 0.15 mg/ml; aluminium (adjuvant) mineral-aluminium other 0.0 mg/ml - immunotherapy - cattle | lamb | sheep | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | ewe | hei - black disease | blackleg | dysentery | enterotoxaemia (pulpy kidney) | haemorrhagic enterotoxaemia | malignant oedema | post parturient gangrene | swelled head | tetanus | tick fever - bovine babesiosis | babesia bigemina | babesia bovis | clostridium perfringens type d | red water | redwater | tetanus vaccination

Филипини - английски - FDA (Food And Drug Administration)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated clostridium perfringens b and e , clostridium novyi a , clostridium septicum a , clostridium chauvoei , clostridium tetani vaccine (vet.) - suspension for injection (im/sc) - formulation: each 2 ml (dose) contains: clostridium perfringens (type b, c, and d) b toxoid .................... > 10 iu/ml clostridium perfringens (type b, c, and d) e toxoid............. >3.5 iu/ml clostridium novyi (type b) a toxoid......... > 2.5 iu/ml clostridium septicum a toxoid ............. clostridium chauvoei ............ ........... 100 % protection clostridium tetani toxoid........... > 2.5 iu/ml

Испания - английски - HMA (Heads of Medicines Agencies)

ceva salud animal - clostridium chauvoei 90 %, clostridium novyi alpha toxoid 3.5 iu/ml, clostridium perfringens a 1.1 iu/ml, clostridium perfringens type c toxoid 10 iu/ml, clostridium perfringens type d toxoid 5 iu/ml, clostridium septicum 2.5 iu/ml, clostridium sordelli 100 %, clostridium tetani toxoid 2.5 iu/ml - suspension for injection - sheep food - clostridium vaccine

Италия - английски - HMA (Heads of Medicines Agencies)

ceva salud animal - clostridium chauvoei 90 %, clostridium novyi alpha toxoid 3.5 iu/ml, clostridium perfringens a 1.1 iu/ml, clostridium perfringens type c toxoid 10 iu/ml, clostridium perfringens type d toxoid 5 iu/ml, clostridium septicum 2.5 iu/ml, clostridium sordelli 100 %, clostridium tetani toxoid 2.5 iu/ml - suspension for injection - sheep food - clostridium vaccine

Австралия - английски - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - thiomersal; selenium as sodium selenate; clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid - parenteral liquid/solution/suspension - thiomersal mercury active 0.13 mg/ml; selenium as sodium selenate mineral-selenium active 0.5 mg/ml; clostridium chauvoei - toxoid vaccine-toxoid active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 3.5 iu/ml; clostridium perfringens type d toxoid vaccine-toxoid active 5.0 iu/ml; clostridium septicum - toxoid vaccine-toxoid active 2.5 iu/ml; clostridium tetani - toxoid vaccine-toxoid active 2.5 iu/ml - immunotherapy - lamb | ovine - black disease | blackleg | enterotoxaemia (pulpy kidney) | malignant oedema | selenium deficiency | tetanus | unthriftiness | white muscle disease | clostridium perfringens type d | ill - thrift | selenium deficiency | selenium responsive ill-thrift | stiff lamb disease | subacute enzootic muscular dys | tetanus vaccination | white muscle disease

Австралия - английски - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - clostridium perfringens type d toxoid; clostridium tetani - toxoid; corynebacterium pseudotuberculosis - toxoid; thiomersal - parenteral liquid/solution/suspension - clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium tetani - toxoid vaccine-toxoid active 0.0 p; corynebacterium pseudotuberculosis - toxoid vaccine-toxoid active 0.0 p; thiomersal mercury other 0.13 g/l - immunotherapy - sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - cheesy gland | enterotoxaemia (pulpy kidney) | tetanus | clostridium perfringens type d | lymphadenitis | lymphangitis | tetanus vaccination

Нова Зеландия - английски - Ministry for Primary Industries

schering-plough animal health limited - clostridium perfringens type d toxoid; clostridium tetani toxoid; clostridium novyi type b toxoid/cells; clostridium septicum toxoid; leptospira interrogans serovar pomona; leptospira borgpetersenii serovar hardjo; clostridium chauvoei toxoid/cells - clostridium perfringens type d toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium septicum toxoid 0 vaccine; leptospira interrogans serovar pomona 0 vaccine; leptospira borgpetersenii serovar hardjo 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine - vaccine

Нова Зеландия - английски - Ministry for Primary Industries

elanco new zealand - clostridium perfringens type d toxoid; clostridium septicum toxoid; sodium selenate; hydroxocobalamin; clostridium novyi type b toxoid/cells; clostridium tetani toxoid; clostridium chauvoei toxoid/cells - clostridium perfringens type d toxoid 0 vaccine; clostridium septicum toxoid 0 vaccine; sodium selenate 2.4 g/litre; hydroxocobalamin 0.5 g/litre; clostridium novyi type b toxoid/cells 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine - parenteral nutrient/electrolyte